Literature DB >> 18070904

Evasion of innate immune responses: evidence for mannose binding lectin inhibition of tumor necrosis factor alpha production by macrophages in response to Blastomyces dermatitidis.

Adi Koneti1, Michael J Linke, Elmer Brummer, David A Stevens.   

Abstract

Serum factors, including mannose binding lectins (MBL), influence innate responses to microbes. Little is known about the effects of serum factors or MBL on the interaction of Blastomyces dermatitidis, a pulmonary fungal pathogen, with macrophages or on tumor necrosis factor alpha (TNF-alpha) production. Since macrophage production of TNF-alpha is an important innate immune response, we examined a mouse peritoneal macrophage (PM) cell line (RAW) and resident PM from CD-1 mice to study TNF-alpha production by PM stimulated with heat-killed (HK) or live B. dermatitidis yeast cells. Mouse serum and heat-inactivated mouse serum inhibited TNF-alpha production 94% when macrophages were stimulated by B. dermatitidis, whereas mouse immunoglobulin G (IgG) did not have this effect. HK B. dermatitidis incubated with serum and then washed also failed to stimulate significant TNF-alpha production by PM. By the sandwich immunofluorescent antibody (IFA) method with anti-mouse MBL (MBL-A or -C), we showed that serum MBL bound to B. dermatitidis. When serum was absorbed with HK B. dermatitidis or live B. dermatitidis, absorbed serum failed to significantly inhibit TNF-alpha production by RAW cells plus B. dermatitidis, and immunoblotting showed that absorbed serum was depleted of MBL-C. If serum was absorbed with live B. dermatitidis, unbound serum was eluted, and bound serum factor(s) (BS) was released with guanidine buffer, BS inhibited TNF-alpha production by PM plus B. dermatitidis in a concentration-dependent manner. BS contained MBL-C, which bound B. dermatitidis, as shown by IFA assay. 1,3-beta-Glucan stimulated TNF-alpha production by PM, and this was inhibited by mouse serum. Treatment of B. dermatitidis with anti-1,3-beta-glucan antibody inhibited TNF-alpha production by PM. With anti-1,3-beta-glucan antibody, we showed by IFA assay that B. dermatitidis contained 1,3-beta-glucan. In an IFA study with B. dermatitidis, serum with an anti-mouse IgG conjugate did not result in fluorescence, yet serum blocked IFA staining of B. dermatitidis by anti-1,3-beta-glucan IgG antibody. This indicated that non-IgG serum factors binding to B. dermatitidis prevented access to 1,3-beta-glucan by anti-1,3-beta-glucan antibody. These results suggest that the mechanism of inhibition of the innate proinflammatory immune response of PM to B. dermatitidis is mediated by serum MBL binding to B. dermatitidis at 1,3-beta-glucan sites or sterically masking 1,3-beta-glucan sites, thus preventing 1,3-beta-glucan stimulation of PM for TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070904      PMCID: PMC2258846          DOI: 10.1128/IAI.01185-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

2.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Virulent isolates and mutants of Blastomyces in mice: a legacy for studies of pathogenesis.

Authors:  D A Stevens; E Brummer; A F DiSalvo; A Ganer
Journal:  Semin Respir Infect       Date:  1997-09

4.  Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.

Authors:  W Chaka; A F Verheul; V V Vaishnav; R Cherniak; J Scharringa; J Verhoef; H Snippe; A I Hoepelman
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

5.  Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses.

Authors:  H Liu; L Jensen; S Hansen; S V Petersen; K Takahashi; A B Ezekowitz; F D Hansen; J C Jensenius; S Thiel
Journal:  Scand J Immunol       Date:  2001-05       Impact factor: 3.487

6.  Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B.

Authors:  D L Jack; R C Read; A J Tenner; M Frosch; M W Turner; N J Klein
Journal:  J Infect Dis       Date:  2001-09-26       Impact factor: 5.226

7.  High-level TNF-alpha secretion and macrophage activity with soluble beta-glucans from Saccharomyces cerevisiae.

Authors:  Do-Youn Lee; In-Hye Ji; Hyo-Ihl Chang; Chan-Wha Kim
Journal:  Biosci Biotechnol Biochem       Date:  2002-02       Impact factor: 2.043

8.  Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release.

Authors:  Cristina Casals; Javier Arias-Diaz; Fernando Valino; Alejandra Saenz; Cruz Garcia; Jose L Balibrea; Elena Vara
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11-15       Impact factor: 5.464

9.  Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide.

Authors:  Janet A Willment; Hsi-Hsien Lin; Delyth M Reid; Philip R Taylor; David L Williams; Simon Y C Wong; Siamon Gordon; Gordon D Brown
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

10.  Dectin-1 is a major beta-glucan receptor on macrophages.

Authors:  Gordon D Brown; Philip R Taylor; Delyth M Reid; Janet A Willment; David L Williams; Luisa Martinez-Pomares; Simon Y C Wong; Siamon Gordon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  9 in total

Review 1.  Fungal killing by mammalian phagocytic cells.

Authors:  André Moraes Nicola; Arturo Casadevall; David L Goldman
Journal:  Curr Opin Microbiol       Date:  2008-06-21       Impact factor: 7.934

2.  Insights into Fungal Morphogenesis and Immune Evasion: Fungal conidia, when situated in mammalian lungs, may switch from mold to pathogenic yeasts or spore-forming spherules.

Authors:  Greg Gauthier; Bruce S Klein
Journal:  Microbe Wash DC       Date:  2008-09

Review 3.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

4.  Surfactant protein D facilitates Cryptococcus neoformans infection.

Authors:  Scarlett Geunes-Boyer; Michael F Beers; John R Perfect; Joseph Heitman; Jo Rae Wright
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

5.  Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system.

Authors:  Ying Jie Ma; Andrea Doni; Mikkel-Ole Skjoedt; Christian Honoré; Maiken Arendrup; Alberto Mantovani; Peter Garred
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

Review 6.  Toll-like receptors (TLRs) and mannan-binding lectin (MBL): on constant alert in a hostile environment.

Authors:  Ingrid-Maria Bergman
Journal:  Ups J Med Sci       Date:  2011-02-17       Impact factor: 2.384

Review 7.  Fungal Dimorphism and Virulence: Molecular Mechanisms for Temperature Adaptation, Immune Evasion, and In Vivo Survival.

Authors:  Gregory M Gauthier
Journal:  Mediators Inflamm       Date:  2017-05-23       Impact factor: 4.711

Review 8.  Evasion Mechanisms Used by Pathogens to Escape the Lectin Complement Pathway.

Authors:  Anne Rosbjerg; Ninette Genster; Katrine Pilely; Peter Garred
Journal:  Front Microbiol       Date:  2017-05-12       Impact factor: 5.640

Review 9.  Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces.

Authors:  Joseph A McBride; Gregory M Gauthier; Bruce S Klein
Journal:  Virulence       Date:  2018-08-01       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.